Your browser doesn't support javascript.
loading
A Randomized, Placebo-Controlled Trial of Pembrolizumab Plus Chemotherapy in Patients With Metastatic Squamous NSCLC: Protocol-Specified Final Analysis of KEYNOTE-407.
Paz-Ares, Luis; Vicente, David; Tafreshi, Ali; Robinson, Andrew; Soto Parra, Hector; Mazières, Julien; Hermes, Barbara; Cicin, Irfan; Medgyasszay, Balazs; Rodríguez-Cid, Jerónimo; Okamoto, Isamu; Lee, SungSook; Ramlau, Rodryg; Vladimirov, Vladimir; Cheng, Ying; Deng, Xuan; Zhang, Ying; Bas, Tuba; Piperdi, Bilal; Halmos, Balazs.
Afiliação
  • Paz-Ares L; Department of Medical Oncology, Hospital Universitario 12 de Octubre, H12o-CNIO Lung Cancer Unit, Universidad Complutense & Ciberonc, Madrid, Spain. Electronic address: lpazaresr@seom.org.
  • Vicente D; Department of Clinical Oncology, Hospital Universitario Virgen Macarena, Sevilla, Spain.
  • Tafreshi A; Wollongong Oncology, Wollongong Private Hospital, Wollongong, New South Wales, Australia.
  • Robinson A; Cancer Centre of Southeastern Ontario, Kingston General Hospital, Kingston, Ontario, Canada.
  • Soto Parra H; Azienda Ospedaliero Universitaria Policlinico Vittorio Emanuele, Catania, Italy.
  • Mazières J; Hôpital Larrey, Centre Hospitalier Universitaire Toulouse, Toulouse, France.
  • Hermes B; Universitätskinikum Tübingen, Tuebingen, Germany.
  • Cicin I; Department of Medical Oncology, Trakya University, Edirne, Turkey.
  • Medgyasszay B; Veszprém Megyei Tüdogyógyintézet Farkasgyepu, Farkasgyepu, Hungary.
  • Rodríguez-Cid J; Oncology Center, Medica Sur Hospital, Mexico City, Mexico.
  • Okamoto I; Department of Medicine and Surgery, Kyushu University Hospital, Fukuoka, Japan.
  • Lee S; Department of Hematology-Oncology, Inje University College of Medicine, Busan, South Korea.
  • Ramlau R; Department of Oncology, Poznan University of Medical Sciences, Poznan, Poland.
  • Vladimirov V; Pyatigorsk Oncology Dispensary, State Healthcare Institute, Pyatigorsk, Russia.
  • Cheng Y; Department of Oncology, Cancer Hospital of Jilin Province, Changchun, People's Republic of China.
  • Deng X; Merck & Co., Inc., Kenilworth, New Jersey.
  • Zhang Y; HTA Statistics Europe, Merck Sharp & Dohme, Brussels, Belgium.
  • Bas T; Merck & Co., Inc., Kenilworth, New Jersey.
  • Piperdi B; Merck & Co., Inc., Kenilworth, New Jersey.
  • Halmos B; Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.
J Thorac Oncol ; 15(10): 1657-1669, 2020 10.
Article em En | MEDLINE | ID: mdl-32599071
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles / 6_other_respiratory_diseases / 6_trachea_bronchus_lung_cancer Assunto principal: Carcinoma de Células Escamosas / Neoplasias Pulmonares Tipo de estudo: Clinical_trials / Guideline Limite: Humans Idioma: En Revista: J Thorac Oncol Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles / 6_other_respiratory_diseases / 6_trachea_bronchus_lung_cancer Assunto principal: Carcinoma de Células Escamosas / Neoplasias Pulmonares Tipo de estudo: Clinical_trials / Guideline Limite: Humans Idioma: En Revista: J Thorac Oncol Ano de publicação: 2020 Tipo de documento: Article